Surface immobilization of hexa-histidine-tagged adeno-associated viral vectors for localized gene delivery

Gene Therapy

Volumn 17, Issue 11, 2010, Pages 1384-1389

  Jang, J H ^a,b   Koerber, J T ^a   Gujraty, K ^c   Bethi, S R ^c   Kane, R S ^c   Schaffer, D V ^a,d  

^a University of California   (United States)

^b Yonsei University   (South Korea)

^c RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^d University of California at Berkeley   (United States)

Author keywords

AAV; hexa histidine; localized gene delivery; substrate mediated gene delivery

Indexed keywords

HISTIDINE; PARVOVIRUS VECTOR;

ARTICLE; BINDING AFFINITY; GENE THERAPY; GENETIC ENGINEERING; IMMOBILIZATION; METAL BINDING; NONHUMAN; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM;

CELLS, CULTURED; DEPENDOVIRUS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HISTIDINE; HUMANS; OLIGOPEPTIDES; TRANSDUCTION, GENETIC;

EID: 78149465127     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2010.81     Document Type: Article

References (23)

1. Fisher KJ, Jooss K, Alston J, Yang Y, Haecker SE, High K et al. Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med 1997; 3: 306-312.
2. Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994; 8: 148-154. (Pubitemid 24308362)
3. Flannery JG, Zolotukhin S, Vaquero MI, LaVail MM, Muzyczka N, Hauswirth WW. Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc Natl Acad Sci USA 1997; 94: 6916-6921.
4. Maguire AM, Simonelli F, Pierce EA, Pugh Jr EN, Mingozzi F, Bennicelli J et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 2008; 358: 2240-2248.
5. Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 2008; 358: 2231-2239.
6. Selkirk SM. Gene therapy in clinical medicine. Postgrad Med J 2004; 80: 560-570.
7. Hu WW, Wang Z, Hollister SJ, Krebsbach PH. Localized viral vector delivery to enhance in situ regenerative gene therapy. Gene Ther 2007; 14: 891-901.
8. Stachelek SJ, Song C, Alferiev I, Defelice S, Cui X, Connolly JM et al. Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants. Gene Ther 2004; 11: 15-24.
9. Jang JH, Houchin TL, Shea LD. Gene delivery from polymer scaffolds for tissue engineering. Expert Rev Med Devices 2004; 1: 127-138.
10. Mizuguchi H, Hayakawa T. Targeted adenovirus vectors. Hum Gene Ther 2004; 15: 1034-1044.
11. Barnett BG, Crews CJ, Douglas JT. Targeted adenoviral vectors. Biochim Biophys Acta 2002; 1575: 1-14.
12. Jang JH, Bengali Z, Houchin TL, Shea LD. Surface adsorption of DNA to tissue engineering scaffolds for efficient gene delivery. J Biomed Mater Res A 2006; 77: 50-58.
13. Lei P, Padmashali RM, Andreadis ST. Cell-controlled and spatially arrayed gene delivery from fibrin hydrogels. Biomaterials 2009; 30: 3790-3799.
14. Yue TW, Chien WC, Tseng SJ, Tang SC. EDC/NHS-mediated heparinization of small intestinal submucosa for recombinant adeno-associated virus serotype 2 binding and transduction. Biomaterials 2007; 28: 2350-2357.
15. Fishbein I, Alferiev IS, Nyanguile O, Gaster R, Vohs JM, Wong GS et al. Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents. Proc Natl Acad Sci USA 2006; 103: 159-164.
16. Mei L, Jin X, Song C, Wang M, Levy RJ. Immobilization of gene vectors on polyurethane surfaces using a monoclonal antibody for localized gene delivery. J Gene Med 2006; 8: 690-698.
17. Koerber JT, Jang JH, Yu JH, Kane RS, Schaffer DV. Engineering adeno-associated virus for one-step purification via immobilized metal affinity chromatography. Hum Gene Ther 2007; 18: 367-378.
18. Arnold GS, Sasser AK, Stachler MD, Bartlett JS. Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes. Mol Ther 2006; 14: 97-106.
19. Duan D, Yue Y, Yan Z, Yang J, Engelhardt JF. Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J Clin Invest 2000; 105: 1573-1587.
20. Summerford C, Samulski RJ. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998; 72: 1438-1445.
21. Girod A, Ried M, Wobus C, Lahm H, Leike K, Kleinschmidt J et al. Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2. Nat Med 1999; 5: 1052-1056.
22. Koerber JT, Maheshri N, Kaspar BK, Schaffer DV. Construction of diverse adeno-associated viral libraries for directed evolution of enhanced gene delivery vehicles. Nat Protoc 2006; 1: 701-706.
23. Maheshri N, Koerber JT, Kaspar BK, Schaffer DV. Directed evolution of adeno-associated virus yields enhanced gene delivery vectors. Nat Biotechnol 2006; 24: 198-204.